Discover SYNTHEMA!
The project aims to create a hub to develop and validate Artificial Intelligence techniques for anonymization and synthetic data generation in rare hematological diseases.
SYNTHEMA (Synthetic generation of hematological data over federated computing frameworks), the project under the frame of HORIZON-HLTH-2022-IND-13: A competitive health-related industry, aims to establish a cross-border data hub to develop and validate innovative artificial intelligence-based techniques for clinical data anonymisation and synthetic data generation, to:
- tackle the scarcity and fragmentation of data and,
- widen the basis for GDPR compliant research in rare hematological diseases (RHDs).
The project will focus on two representative RHD use cases: sickle-cell disease (SCD) and acute myeloid leukaemia (AML).
SYNTHEMA will be developed with the collaboration of 16 partners from 10 countries (Spain, Italy, Austria, United Kingdom, Belgium, Netherlands, France, Germany, Portugal and Luxembourg) and under the coordination of Dr. Federico Álvarez from Universidad Politecnica Madrid (Spain).
The four-year project is endorsed by ERN-EuroBloodNet and counts on the participation of ERN-EuroBloodNet experts:
- Humanitas Mirasole - Matteo Giovanni Della Porta
- Universitair Medisch Centrum Utrecht - Eduard van Beers
- Vall d'Hebron Institut de Recerca - María del Mar Mañú Pereira
- Assistance Publique - Hôpitaux de Paris - Pablo Bartolucci
- Charité - Universitaetsmedizin Berlin - Lars Bullinger and Anna Dolink
- Universita Degli Studi di Padova - Raffaella Colombatti, Gianni Bisogno, Marta Tremoleda and Renzo Manara
During the month of December, the Kick-off meeting has been celebrated (Madrid, Spain) and the first press release has been launched. Stay tuned to their social media channels @synthema_eu (Twitter) and /synthema (LinkedIn) to not miss the advances!
